Where is Rappaport when youse need him? Looks like NGSX ain't got either the bux or the science to do further clinical studies to make red hot chili pepper on a patch available to the HIV/AIDS community. Bummer. Surely Hussein and Rappaport can come up with an NIH study to do the job!
Our POTUS can sing; can he rap with Rappaport and come up with a plan to test Cue10Zah at government expense for the good of the HIV/AIDS community? I still B on D sidelines awaiting to invest in NGSX; I needs a good financial justification to put my money where my keyboard is. All IMHO.
7:30AM Neurogesx provides update on NGX-1998 clinical program: end of Phase 2 meeting with FDA expected in Q3 (NGSX) 0.39 : Co announced that the FDA has accepted the co's request for an End-of-Phase 2 meeting to discuss the continued clinical investigation of NGX-1998 as a treatment for certain neuropathic pain conditions including, specifically, the Company's plans for entering NGX-1998 into Phase 3 development. The Company anticipates that the End-of-Phase 2 meeting will occur in the third quarter of 2012.
Market Data 
Markets 
AI
